PortfoliosLab logoPortfoliosLab logo
Teladoc Health, Inc. (TDOC)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US87918A1051
CUSIP
87918A105
IPO Date
Jul 1, 2015

Highlights

Market Cap
$960.41M
Enterprise Value
$1.21B
EPS (TTM)
-$1.14
Total Revenue (TTM)
$2.53B
Gross Profit (TTM)
$1.76B
EBITDA (TTM)
$9.64M
Year Range
$4.40 - $9.77
Target Price
$8.17
ROA (TTM)
-7.01%
ROE (TTM)
-14.46%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Teladoc Health, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Teladoc Health, Inc. (TDOC) has returned -22.14% so far this year and -31.53% over the past 12 months. Over the last ten years, TDOC has returned -5.93% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.


Teladoc Health, Inc.

1D
6.03%
1M
3.61%
YTD
-22.14%
6M
-29.50%
1Y
-31.53%
3Y*
-40.52%
5Y*
-50.47%
10Y*
-5.93%

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jul 1, 2015, TDOC's average daily return is +0.01%, while the average monthly return is -0.01%.

Historically, 50% of months were positive and 50% were negative. The best month was Jun 2016 with a return of +40.2%, while the worst month was Apr 2022 at -53.2%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 6 months.

On a daily basis, TDOC closed higher 50% of trading days. The best single day was Jul 26, 2023 with a return of +27.0%, while the worst single day was Apr 28, 2022 at -40.2%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-22.14%-3.49%3.61%-22.14%
202511.77%-5.91%-16.74%-9.67%-3.76%25.87%-17.22%7.21%0.00%11.64%-12.05%-7.77%-22.99%
2024-9.84%-22.39%0.13%-15.56%-11.84%-12.99%-3.58%-23.97%28.03%-1.96%33.11%-24.12%-57.82%
202324.31%-9.90%-2.23%2.43%-12.74%9.37%17.58%-23.95%-17.89%-11.03%9.67%18.80%-8.88%
2022-16.46%-1.04%-4.98%-53.20%0.98%-2.58%10.96%-15.71%-18.38%16.92%-3.81%-17.05%-74.24%
202131.94%-16.20%-17.79%-5.17%-12.63%10.43%-10.73%-2.71%-12.19%17.96%-32.31%-9.31%-54.08%

Benchmark Metrics

Teladoc Health, Inc. has an annualized alpha of -10.55%, beta of 1.19, and R² of 0.12 versus S&P 500 Index. Calculated based on daily prices since July 02, 2015.

  • This stock participated in 182.21% of S&P 500 Index downside but only 83.68% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.12 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-10.55%
Beta
1.19
0.12
Upside Capture
83.68%
Downside Capture
182.21%

Return for Risk

Risk / Return Rank

TDOC ranks 17 for risk / return — in the bottom 17% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


TDOC Risk / Return Rank: 1717
Overall Rank
TDOC Sharpe Ratio Rank: 1717
Sharpe Ratio Rank
TDOC Sortino Ratio Rank: 1717
Sortino Ratio Rank
TDOC Omega Ratio Rank: 1919
Omega Ratio Rank
TDOC Calmar Ratio Rank: 2020
Calmar Ratio Rank
TDOC Martin Ratio Rank: 1313
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Teladoc Health, Inc. (TDOC) and compare them to a chosen benchmark (S&P 500 Index).


TDOCBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.55

0.90

-1.45

Sortino ratio

Return per unit of downside risk

-0.58

1.39

-1.97

Omega ratio

Gain probability vs. loss probability

0.94

1.21

-0.27

Calmar ratio

Return relative to maximum drawdown

-0.62

1.40

-2.02

Martin ratio

Return relative to average drawdown

-1.36

6.61

-7.97

Explore TDOC risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Teladoc Health, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Teladoc Health, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Teladoc Health, Inc. was 98.48%, occurring on Feb 12, 2026. The portfolio has not yet recovered.

The current Teladoc Health, Inc. drawdown is 98.15%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.48%Feb 9, 20211259Feb 12, 2026
-72.72%Aug 5, 2015162Mar 28, 2016310Jun 19, 2017472
-50.34%Oct 1, 201859Dec 24, 2018259Jan 6, 2020318
-30.86%Aug 5, 202069Nov 10, 202049Jan 22, 2021118
-24.19%Sep 15, 201744Nov 15, 201710Nov 30, 201754

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Teladoc Health, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Teladoc Health, Inc. is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for TDOC relative to other companies in the Health Information Services industry. Currently, TDOC has a P/S ratio of 0.4. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for TDOC in comparison with other companies in the Health Information Services industry. Currently, TDOC has a P/B value of 0.7. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items